InfoBionic.Ai's vision is to deliver the first mobile cardiac telemetry platform capable of supporting nearly any level of acuity where virtual care is delivered.
Gerardo Ibarra · Executive Officer, Director · decision-maker
David MacCutcheon · Executive Officer · decision-maker
Stuart Long · Executive Officer, Director · decision-maker
Anna McNamara · Executive Officer · decision-maker
Careers mailbox is known
Sep 29, 2023
Raised a round Venture round $57.8M · SEC Form D
No named decision-maker yet.
Careers mailbox is known
2022
Founded
Clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS).
Maria Palasis · Director, Executive Officer · decision-maker
John Bishop Ph.D. · Executive Officer · decision-maker
Richard Nieman M.D. · Executive Officer · decision-maker
Corinne Noyes · Executive Officer · decision-maker
Careers mailbox is known
May 25, 2023
Raised a round Venture round $50M · SEC Form D
High impact solutions for patients.. Companies Founded.
No named decision-maker yet.
No careers mailbox known
Maxwell Biomedical is developing Cardiomodulation, a non-destructive electrical therapy for atrial fibrillation designed to preserve atrial function.
No named decision-maker yet.
Careers mailbox is known
Ryan Gladney · Executive Officer · decision-maker
Joshua Woolley · Executive Officer · decision-maker
Gary Graham · Executive Officer · decision-maker
Peter DeLange · Executive Officer · decision-maker
No careers mailbox known
Aug 6, 2025
Raised a round Venture round $1.4M · SEC Form D
Alleviant Medical's interatrial shunt therapy without an implant is currently being evaluated in heart failure patients. FDA approved clinical trial programs.
Adam Berman · Executive Officer, Director · decision-maker
Albertien Greijdanus · Executive Officer, Director · decision-maker
Christopher Arevalos · Executive Officer, Director · decision-maker
Avni Patel · Executive Officer, Director · decision-maker
Careers mailbox is known
Dec 19, 2024
Raised a round Venture round $90.8M · SEC Form D
2017
Founded
Redefining mitral valve repair with CARLEN — a single-leaflet solution expanding options for TEER-eligible and previously untreatable patients.
Sai Muralidhar Padala · Executive Officer, Director · decision-maker
Lisa Heine · Director
Gowri Raman · Director
Eric Sarin · Director
No careers mailbox known
2025
Team of 17 was 12 · US Form 5500 (plan participants)
Nov 10, 2022
Raised a round Venture round $12M · SEC Form D
2018
Founded
Redefining heart failure by enabling early & safe treatment - Puzzle Medical Devices® Inc. is a Canadian company specializing in the development of a minimally invasive long-term hemodynamic transcatheter pump.
No named decision-maker yet.
Careers mailbox is known
Feb 9, 2023
Raised a round Series A $34M
Sep 1, 2021
Partnership Puzzle Medical announces partnership with Patent Attorney Scott Talbot from U.S. firm Cooley LLP · puzzlemed.com
Jul 7, 2021
Recognition Puzzle Medical named Top 22 Best Montreal Companies · puzzlemed.com
Advancing reversible therapies targeting von Willebrand Factor for safer treatment of acute thrombotic conditions. Precision control when seconds matter.
Julia Owens · Executive Officer, Director · decision-maker
Richard Shea · Executive Officer, Director · decision-maker
Ari Nowacek · Director
David Adair · Director
Careers mailbox is known
Oct 31, 2023
Raised a round Venture round $55M · SEC Form D
2019
Founded
Our purpose is. Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia.
Thomas Johnson · Executive Officer, Director · decision-maker
Michael Young · Executive Officer · decision-maker
Allison August · Executive Officer · decision-maker
Paul Antinori · Executive Officer · decision-maker
No careers mailbox known
Dec 14, 2023
Raised a round Venture round $37.5M · SEC Form D
2020
Founded
Viridian Therapeutics is leveraging core expertise in antibody discovery to develop optimized treatments for rare autoimmune conditions.
Jonathan Violin · Executive Officer, Director · decision-maker
Tomas Kiselak · Director
Peter Harwin · Director
Careers mailbox is known
2025
Team of 240 was 146 · US Form 5500 (plan participants)
Sep 17, 2020
Raised a round Venture round $27M · SEC Form D
2020
Founded
